Rakovina Therapeutics Inc. RKV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.46% | -50.77% | -109.71% | -143.45% | -149.50% |
| Total Depreciation and Amortization | 2.63% | 1.38% | -1.94% | -3.01% | -3.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.37% | 134.85% | 270.30% | 260.82% | 65.88% |
| Change in Net Operating Assets | 338.68% | 545.76% | 360.76% | -306.16% | -211.63% |
| Cash from Operations | 54.33% | -10.72% | -49.50% | -178.82% | -391.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.54% | 21.60% | 1.28% | 296.38% | 384.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 118.05% | 49.58% | 49.58% | -226.24% | -82.43% |
| Cash from Financing | -78.61% | 23.25% | 1.88% | 292.23% | 373.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -428.09% | 809.98% | -213.55% | 203.54% | 209.62% |